ReviewJournal of translational medicine2017

Heterogeneity of Toll-like receptor 9 signaling in B cell malignancies and its potential therapeutic application.

Ling Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.